Regenerative therapies have the potential to transform healthcare by offering curative treatments that restore normal function and improve, extend, or save lives, addressing conditions like cancer, heart disease, and diabetes. However, despite growing global investment, patient access in Australia remains limited due to manufacturing bottlenecks, high costs, and reliance on off-shore solutions. Bridging these gaps is essential to reduce the healthcare burden and ensure Australians benefit from this life-changing innovation.
